Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

    Not recruiting

    1 1 1
    Investigated Drugs:
    France
  • Study of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Finland France
  • Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Bulgaria Czechia France Hungary Italy Poland +2
  • Study of AZD7798 compared to placebo in patients with moderate to severe Crohn’s disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia France Germany +8
  • Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

    Not recruiting

    3 1 1
    Investigated Diseases:
    Germany Italy Poland Spain
  • Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

    Not recruiting

    2 1
    Investigated Drugs:
    Austria Greece Hungary Italy Poland Romania +2
  • Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Poland Spain
  • Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark France Germany +8
  • Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Czechia Denmark Finland Germany Italy +6
  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Hungary Italy The Netherlands Poland +2